Építés alatt – nem éles oldal
Belépés
Csak meghívásosFázis nélkül

Impact of Comparing Treatment Status With Other CPAP Users

A legfontosabb adatok

Ki végzi
Kimihiko Murase
Hol
Japán1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Csak meghívásos
Résztvevők
186 fő, tervezett
Kezdés
2025. okt. 1.
Várható befejezés
2028. jún. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Comparison of the treatment data with other patients
  • CPAP data feedback
A regiszteradat frissítve
2025. december 29.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with sleep apnea who have used CPAP with remote monitoring for at least three months. It tests whether comparing their CPAP use with other patients helps them use it more.

Életkor
20 years and older
Nem
All sexes
A betegség stádiuma
Sleep apnea (SAS) diagnosed and CPAP started under Japanese public health insurance rules, with regular clinic visits to continue CPAP.
Korábbi kezelés
Must be on CPAP therapy. At least three months must have passed since a CPAP remote monitoring system was set up.
Biomarker vagy leletérték
At diagnosis: apnea hypopnea index (AHI) >= 20/h on a sleep study (polysomnography), or respiratory event index (REI) >= 40/h on a portable monitoring device.

A részvétel fő kizáró okai

  • CPAP use already very good: 90% or more of days with >4 hours of use and average >=7 hours per day over the past month
  • No CPAP use at all during the past month
  • Working night shifts twice or more a week
  • Cognitive impairment (problems with memory or thinking)
  • No mailing address for feedback by post or email

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki nem vehet részt

  • When a patient who is a potential participant visits the outpatient clinic for continued CPAP therapy, their CPAP adherence during the previous month will be checked
  • If the patient's background and CPAP adherence over the previous month meet the inclusion criteria, informed consent will be obtained from the patient
  • After the number of patients who have provided consent reaches the planned sample size, a postal item will be sent to confirm the accuracy of the participant's address. The mailing will include a postcard for reply or QR code that allows the research team to verify that the participant has received the item. Participants whose receipt of the mailing can be confirmed will be eligible for randomization
  • Participants will be randomly assigned to either the control group (receiving only information about their own CPAP adherence) or the peer comparison group (receiving information about their own adherence plus the summary of adherence data from all participants)
  • Thereafter, for six months, participants will receive by mail monthly information about their CPAP adherence. Each mailing will include a postcard for reply and a QR code that allow participants to notify the researchers that they have opened the mailing; In the control group, the following information will be provided:(1) Average daily CPAP usage time in the previous month, and (2) Percentage of days with CPAP usage more than or equal to 4 hours per day.In the peer comparison group, in addition to the above, the following information will be provided: (3) Mean daily CPAP usage time among all participants, (4) Percentage of days with CPAP usage ≥ 4 hours per day among all participants, and (5) Participant's rank among all participants based on average daily CPAP usage time
  • Patients with cognitive impairment; Intervention Details
  • Treatment adherence is already sufficiently good, with little need for further improvement. (Defined as a proportion of days with >4 hours of CPAP use of 90% or higher, and an average daily usage time >=7 hours over the past month.)
  • No CPAP usage at all during the past month (for example, due to business trips, caring for family members, or other social reasons resulting in an inability to use CPAP, and for whom improvement in adherence through this intervention is not expected)
  • Working night shifts twice or more a week

Egyéb feltételek

  • Eligibility criteria:
  • The patient has been diagnosed with SAS and has initiated CPAP therapy according to the criteria of Japanese public health insurance system(i.e., Apnea hypopnea index (AHI) >= 20/h by polysomnography, or respiratory event index (REI) is >= 40/h by portable monitoring device at the time of OSA diagnosis)
  • The patient makes regular outpatient visits for the continuation of CPAP therapy according to the requirements for the coverage of Japanese public health insurance
  • At least three months have passed since the introduction of a CPAP remote monitoring system, and the researchers can confirm CPAP adherence online
  • The patient has mailing address necessary for sending feedback by post or email

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The objective of this study is to evaluate whether comparing a patient's own CPAP usage data with that of other patients improves CPAP adherence in patients who have been undergoing long-term CPAP therapy for sleep apnea. Eligible participants are patients who have been on CPAP therapy with remote monitoring of treatment data enabled for at least three months. Participants will be randomly assigned to one of two groups: (1) routine treatment data feedback group, or (2) treatment data comparison group. In both groups, feedback will be provided to participants by mail on monthly basis, including the proportion of days with CPAP usage ≥4 hours per day and the average daily CPAP usage time. In the treatment data comparison group, in addition to this information, aggregated results for all participants (proportion of days with CPAP usage ≥4 hours per day and average daily usage time) and the participant's ranking based on these aggregated data will also be provided as feedback. The observation period will be six months after initiation of the intervention, and changes in treatment adherence before and after the intervention will be assessed.

A vizsgálat 2 csoportja

  • Routine treatment data feedback groupMár használt kezelés, összehasonlításként

    In this group, feedback will be provided to participants by mail on monthly basis, including the proportion of days with CPAP usage ≥4 hours per day and the average daily CPAP usage time.

    Kezelés: CPAP data feedback

  • Treatment data comparison groupA vizsgált kezelés

    In this group, feedback will be provided as in the routine treatment data feedback group. In addition to this information, aggregated results for all participants (proportion of days with CPAP usage ≥4 hours per day and average daily usage time) and the participant's ranking based on these aggregated data will also be provided as feedback.

    Kezelés: Comparison of the treatment data with other patients és CPAP data feedback

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Impact of Comparing Treatment Status With Other Patients on Treatment Adherence in CPAP Therapy.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2025. december 29.